Dynamic Contrast-Enhanced Derived Cerebral Blood Volume Correlates Better With Leak Correction Than With No Correction for Vascular Endothelial Growth Factor, Microvascular Density, and Grading of Astrocytoma-Reference-Cited by-同舟云学术

Dynamic Contrast-Enhanced Derived Cerebral Blood Volume Correlates Better With Leak Correction Than With No Correction for Vascular Endothelial Growth Factor, Microvascular Density, and Grading of Astrocytoma

Published:2008-11 Issue:6 Volume:32 Page:955-965
ISSN:0363-8715
Container-title:Journal of Computer Assisted Tomography
language:en
Short-container-title:Journal of Computer Assisted Tomography

Author:

Haris Mohammad,Husain Nuzhat,Singh Anup,Husain Mazhar,Srivastava Savita,Srivastava Chhitiz,Behari Sanjay,Rathore Ram Kishore S.,Saksena Sona,Gupta Rakesh Kumar

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging

Reference47 articles.

1. The pathology of primary brain tumors

2. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications

3. Role of angiogenesis in tumor growth and metastasis

4. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy;European Journal of Radiology;2023-08

2. Perfusion-weighted imaging in vestibular schwannoma: the influence that cystic status and tumor size have on perfusion profiles;Radiologia Brasileira;2023-03

3. Clinical Applications of Dynamic Contrast-Enhanced (DCE) Permeability Imaging;Functional Neuroradiology;2023

4. Hemodynamic Imaging in Cerebral Diffuse Glioma—Part A: Concept, Differential Diagnosis and Tumor Grading;Cancers;2022-03-10

5. Hemodynamic Imaging in Cerebral Diffuse Glioma—Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions;Cancers;2022-03-05